Edition:
United Kingdom

Altimmune Inc (ALT.OQ)

ALT.OQ on NASDAQ Stock Exchange Global Market

2.13USD
22 Aug 2019
Change (% chg)

$0.01 (+0.47%)
Prev Close
$2.12
Open
$2.11
Day's High
$2.14
Day's Low
$2.10
Volume
8,813
Avg. Vol
58,964
52-wk High
$36.25
52-wk Low
$1.70

About

Altimmune Inc is a clinical-stage immunotherapeutics company. The Company is focused on the development of products to stimulate robust and durable immune responses for the prevention and treatment of disease. The Company’s product candidates include ALT-801, HepTcell, ALT-702, NasoVAX and NasoShield. HepTcell is a synthetic... (more)

Overall

Beta: 3.04
Market Cap(Mil.): $31.61
Shares Outstanding(Mil.): 13.45
Dividend: --
Yield (%): --

Financials

  ALT.OQ Industry Sector
P/E (TTM): -- 98.31 33.85
EPS (TTM): -15.41 -- --
ROI: -64.89 7.52 12.69
ROE: -80.04 7.94 17.13
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates